EUVIMEDEUVIMED entdecken
Crossref

Fungi as a Source of Enzyme Inhibitors: Bioprospecting for New Drugs

Sanjai Saxena

Mycological Spectrum · 2026

DOI: 10.64993/ms.2.1.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mycological Spectrum, 2026. Verfasst von Sanjai Saxena.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fungi are prolific producers of structurally diverse secondary metabolites, many of which serve as potent enzyme inhibitors with therapeutic potential.Targeting important enzymes linked to cancer, diabetes, neurodegenerative, infectious, and metabolic diseases, this review examines fungal-derived enzyme inhibitors discovered between 2015 and 2025 based on research published in Google Scholar, ScienceDirect, Web of Knowledge, and Scopus.The study highlights fungal metabolites that inhibit proteasomes, tyrosine phosphatases (PTP1B), αglucosidase, cholinesterase, BACE1, GSK-3, viral neuraminidase, histone acetyltransferases, and isocitrate dehydrogenases, among others.These bioactive compounds, sourced from fungi inhabiting diverse ecological niches-marine, endophytic, soil, and symbiotic-demonstrate unique chemotypes and novel mechanisms of enzyme inhibition.Their broad-spectrum activity and structural novelty present promising scaffolds for drug development.Fungi's amenability to fermentation, coupled with advances in genomics, synthetic biology, and computational tools, has enabled accelerated discovery and optimization of enzyme inhibitors.However, challenges such as suboptimal pharmacokinetics and potential toxicity necessitate rigorous in silico and experimental screening.The review underscores fungi as an underexploited reservoir for enzyme-targeted therapeutics and advocates continued bioprospecting and molecular characterization to unlock their full pharmaceutical potential.Integrating fungal chemical diversity with modern drug discovery platforms could significantly advance the development of next-generation therapeutics.

Zitieren

APA

Saxena, S. (2026). Fungi as a Source of Enzyme Inhibitors: Bioprospecting for New Drugs. Mycological Spectrum. https://doi.org/10.64993/ms.2.1.2

Vancouver

Saxena S. Fungi as a Source of Enzyme Inhibitors: Bioprospecting for New Drugs. Mycological Spectrum. 2026. doi:10.64993/ms.2.1.2

BibTeX
@article{Saxena2026,
  author = {Saxena, Sanjai},
  title = {Fungi as a Source of Enzyme Inhibitors: Bioprospecting for New Drugs},
  journal = {Mycological Spectrum},
  year = {2026},
  doi = {10.64993/ms.2.1.2}
}
Kostenlos starten →